company background image
CLBT logo

Cellebrite DI NasdaqGS:CLBT Stock Report

Last Price

US$11.71

Market Cap

US$2.3b

7D

2.8%

1Y

102.9%

Updated

25 Feb, 2024

Data

Company Financials +

CLBT Stock Overview

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the United States, and the Asia-Pacific.

CLBT fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Cellebrite DI Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cellebrite DI
Historical stock prices
Current Share PriceUS$11.71
52 Week HighUS$11.92
52 Week LowUS$5.22
Beta1.44
1 Month Change26.59%
3 Month Change38.74%
1 Year Change102.95%
3 Year Change12.38%
5 Year Changen/a
Change since IPOn/a

Recent News & Updates

Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17

Feb 18
Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17

There's Reason For Concern Over Cellebrite DI Ltd.'s (NASDAQ:CLBT) Price

Jan 28
There's Reason For Concern Over Cellebrite DI Ltd.'s (NASDAQ:CLBT) Price

Recent updates

Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17

Feb 18
Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17

There's Reason For Concern Over Cellebrite DI Ltd.'s (NASDAQ:CLBT) Price

Jan 28
There's Reason For Concern Over Cellebrite DI Ltd.'s (NASDAQ:CLBT) Price

Is Cellebrite DI Ltd. (NASDAQ:CLBT) Trading At A 39% Discount?

Nov 04
Is Cellebrite DI Ltd. (NASDAQ:CLBT) Trading At A 39% Discount?

Calculating The Intrinsic Value Of Cellebrite DI Ltd. (NASDAQ:CLBT)

May 26
Calculating The Intrinsic Value Of Cellebrite DI Ltd. (NASDAQ:CLBT)

We Ran A Stock Scan For Earnings Growth And Cellebrite DI (NASDAQ:CLBT) Passed With Ease

Apr 29
We Ran A Stock Scan For Earnings Growth And Cellebrite DI (NASDAQ:CLBT) Passed With Ease

Is Now The Time To Look At Buying Cellebrite DI Ltd. (NASDAQ:CLBT)?

Mar 16
Is Now The Time To Look At Buying Cellebrite DI Ltd. (NASDAQ:CLBT)?

Cellebrite DI Ltd. (NASDAQ:CLBT) Held Back By Insufficient Growth Even After Shares Climb 33%

Feb 16
Cellebrite DI Ltd. (NASDAQ:CLBT) Held Back By Insufficient Growth Even After Shares Climb 33%

Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?

Feb 09
Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?

Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?

Oct 18
Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?

Cellebrite: A Niche Company With A Large TAM

Sep 30

Cellebrite DI Lowers Sights For 2022

Aug 30

Cellebrite Non-GAAP EPS of $0.00 misses by $0.03, revenue of $62.6M misses by $6.5M

Aug 11

Cellebrite DI Ltd.'s (NASDAQ:CLBT) Intrinsic Value Is Potentially 61% Above Its Share Price

Jul 08
Cellebrite DI Ltd.'s (NASDAQ:CLBT) Intrinsic Value Is Potentially 61% Above Its Share Price

Estimating The Fair Value Of Cellebrite DI Ltd. (NASDAQ:CLBT)

Mar 07
Estimating The Fair Value Of Cellebrite DI Ltd. (NASDAQ:CLBT)

Shareholder Returns

CLBTUS SoftwareUS Market
7D2.8%0.2%1.3%
1Y102.9%59.2%25.6%

Return vs Industry: CLBT exceeded the US Software industry which returned 59.2% over the past year.

Return vs Market: CLBT exceeded the US Market which returned 25.6% over the past year.

Price Volatility

Is CLBT's price volatile compared to industry and market?
CLBT volatility
CLBT Average Weekly Movement5.5%
Software Industry Average Movement7.6%
Market Average Movement6.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: CLBT's share price has been volatile over the past 3 months.

Volatility Over Time: CLBT's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19991,005Yossi Carmilhttps://www.cellebrite.com

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the United States, and the Asia-Pacific. Its DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company’s Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light.

Cellebrite DI Ltd. Fundamentals Summary

How do Cellebrite DI's earnings and revenue compare to its market cap?
CLBT fundamental statistics
Market capUS$2.31b
Earnings (TTM)-US$81.10m
Revenue (TTM)US$325.11m

7.1x

P/S Ratio

-28.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CLBT income statement (TTM)
RevenueUS$325.11m
Cost of RevenueUS$53.23m
Gross ProfitUS$271.88m
Other ExpensesUS$352.98m
Earnings-US$81.10m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.41
Gross Margin83.63%
Net Profit Margin-24.95%
Debt/Equity Ratio0%

How did CLBT perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.